Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study

Fig. 3

Mean serum concentrations of a activin A, b activin B and c follistatin levels in study participants diagnosed with chronic fatigue syndrome (CFS/ME) compared to activin/follistatin data from a reference population. Ratio of d activin B to follistatin levels (ActB:FST), e activin A to follistatin levels (ActA:FST) and f Ratio of activin B to activin A (ActB:ActA). Data are presented as mean ± SEM

Back to article page